Ario Takeuchi

Fukuoka, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 128 publications

A randomized controlled phase III trial on continued or paused PD-1 pathway blockade for patients with advanced renal cell carcinoma (JCOG1905, STOP study): a study protocol.

A randomized controlled phase III trial on continued or paused PD-1 pathway blockade for patients with advanced renal cell carcinoma (JCOG1905, STOP study): a study protocol.

Journal: Japanese journal of clinical oncology

Published: September 13, 2025

Efficacy and safety of axitinib for metastatic renal cell carcinoma: Real-world data on patients with renal impairment.

Efficacy and safety of axitinib for metastatic renal cell carcinoma: Real-world data on patients with renal impairment.

Journal: Urologic oncology

Published: January 27, 2023

Real-world effectiveness of nivolumab and subsequent therapy in Japanese patients with metastatic renal cell carcinoma (POST-NIVO study): 36-month follow-up results of a clinical chart review.

Real-world effectiveness of nivolumab and subsequent therapy in Japanese patients with metastatic renal cell carcinoma (POST-NIVO study): 36-month follow-up results of a clinical chart review.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: November 28, 2022

Formation and evolution of carbonaceous asteroid Ryugu: Direct evidence from returned samples.

Formation and evolution of carbonaceous asteroid Ryugu: Direct evidence from returned samples.

Journal: Science (New York, N.Y.)

Published: September 22, 2022

Psoas Muscle Volume Is a Predictive Marker of Fatigue and Anorexia in Prostate Cancer Patients Treated with Enzalutamide.

Psoas Muscle Volume Is a Predictive Marker of Fatigue and Anorexia in Prostate Cancer Patients Treated with Enzalutamide.

Journal: JMA journal

Published: April 29, 2022

Testosterone level in seminal vesicle fluid is a better indicator of erectile function than serum testosterone in patients with prostate cancer.

Testosterone level in seminal vesicle fluid is a better indicator of erectile function than serum testosterone in patients with prostate cancer.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: March 01, 2022

Validation of models predicting lymph node involvement probability in patients with prostate cancer.

Validation of models predicting lymph node involvement probability in patients with prostate cancer.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: October 01, 2021

Anticancer Effect of Second-line Treatment for Castration-Resistant Prostate Cancer Following First-line Treatment with Androgen Receptor Pathway Inhibitors.

Anticancer Effect of Second-line Treatment for Castration-Resistant Prostate Cancer Following First-line Treatment with Androgen Receptor Pathway Inhibitors.

Journal: JMA journal

Published: September 06, 2021

Prognostic Value of Lower Tract Urinary Symptoms in Clinically Regional Lymph Node-positive Prostate Cancer.

Prognostic Value of Lower Tract Urinary Symptoms in Clinically Regional Lymph Node-positive Prostate Cancer.

Journal: Anticancer research

Published: August 22, 2021

Differential prognostic impact of complete blood count-related parameters by prior use of novel androgen receptor pathway inhibitors in docetaxel-treated castration-resistant prostate cancer patients.

Differential prognostic impact of complete blood count-related parameters by prior use of novel androgen receptor pathway inhibitors in docetaxel-treated castration-resistant prostate cancer patients.

Journal: Anti-cancer drugs

Published: August 13, 2021

Prognostic impact of dose reduction in androgen receptor pathway inhibitors for castration-resistant prostate cancer.

Prognostic impact of dose reduction in androgen receptor pathway inhibitors for castration-resistant prostate cancer.

Journal: Prostate international

Published: July 30, 2021

Lactate Dehydrogenase Is a Serum Prognostic Factor in Clinically Regional Lymph Node-positive Prostate Cancer.

Lactate Dehydrogenase Is a Serum Prognostic Factor in Clinically Regional Lymph Node-positive Prostate Cancer.

Journal: Anticancer research

Published: June 09, 2021

Showing 1-12 of 128

Last Updated: 09/26/2026